PRIVATE EQUITY: In Cancer Oncology Care


By Ola Abdelhadi

By Richard Scheffler

University California at Berkley



Despite increases in private equity acquisition of oncology practices, little is known about the effect on market competition, prices, and quality.


This research team will examine the changes in health care quality and prices following private equity acquisition of oncology practices and explore whether these acquisitions exacerbate health disparities among racial groups. This work may be relevant to policymakers and antitrust regulators assessing private equity deals.

Increasing Private Equity Investment in Cancer Care: What is the Effect on Prices and Quality of Care?



Thank You




One Response


    There’s a new way to screen for some cancers. Scientists in South Korea have developed a cheap way to detect pancreatic and prostate cancer—and all the patient has to do is pee on a strip.

    They say their sensor, which costs around eight cents, has a 99% success rate in identifying the urine of people with these cancers versus people without. And the team is experimenting further to try to extend it to more cancers, including colon-rectal and lung cancers.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: